Molina Healthcare, Inc. (MOH)
NYSE: MOH · Real-Time Price · USD
151.86
+1.29 (0.86%)
At close: Dec 5, 2025, 4:00 PM EST
151.94
+0.08 (0.05%)
After-hours: Dec 5, 2025, 7:57 PM EST
Molina Healthcare Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Molina Healthcare stock have an average target of 205.67, with a low estimate of 144 and a high estimate of 345. The average target predicts an increase of 35.43% from the current stock price of 151.86.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Molina Healthcare stock from 13 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 10 | 9 | 9 | 9 | 9 | 9 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 12 | 12 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $231 → $165 | Buy | Maintains | $231 → $165 | +8.65% | Nov 12, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $207 → $167 | Hold | Maintains | $207 → $167 | +9.97% | Oct 24, 2025 |
| UBS | UBS | Hold Maintains $180 → $170 | Hold | Maintains | $180 → $170 | +11.95% | Oct 24, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $210 → $180 | Hold | Maintains | $210 → $180 | +18.53% | Oct 24, 2025 |
| Barclays | Barclays | Hold → Sell Downgrades $185 → $144 | Hold → Sell | Downgrades | $185 → $144 | -5.18% | Oct 24, 2025 |
Financial Forecast
Revenue This Year
45.17B
from 39.16B
Increased by 15.34%
Revenue Next Year
47.18B
from 45.17B
Increased by 4.44%
EPS This Year
14.40
from 20.42
Decreased by -29.46%
EPS Next Year
13.57
from 14.40
Decreased by -5.82%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 47.6B | 50.1B | |||
| Avg | 45.2B | 47.2B | |||
| Low | 41.7B | 44.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 21.6% | 10.9% | |||
| Avg | 15.3% | 4.4% | |||
| Low | 6.3% | -2.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 19.37 | 15.21 | |||
| Avg | 14.40 | 13.57 | |||
| Low | 13.23 | 10.78 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -5.1% | 5.6% | |||
| Avg | -29.5% | -5.8% | |||
| Low | -35.2% | -25.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.